Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • XEL vs GSK✓SelectedUSD · GSKXEL vs GSK performance historyLatest closeAs of+0.13%11/13
Stock and ETF performance explorer

XEL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+188.0%
GSK return
+105.0%
Excess return
+83.1%
Maximum drawdown
-34.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.1%+0.5%-0.4%0.0%
7D+2.4%+1.1%+1.3%+2.0%
30D+8.3%+6.3%+2.0%+6.0%
3M+4.2%+1.8%+2.4%+3.2%
6M+3.7%+1.7%+2.1%+2.7%
YTD+13.1%+6.5%+6.5%+9.4%
1Y+5.0%+9.5%-4.5%+0.5%
3Y+55.0%+65.3%-10.3%+23.2%
5Y+51.8%+43.7%+8.1%+25.6%
All+188.0%+105.0%+83.1%+102.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling